2016 -2020 Director and Professor, Ming-Wai Lau Center for Reparative Medicine @
2016 -now Chief Executive Officer and Interim Research and Development Officer @ Novoheart
2016 -now Professor, Dr Li Dak-Sum Research Center, Hku-Ki Collaboration in Regenerative Medicine @
2010 -2015 Director, Stem Cell and Regenerative Medicine Consortium @
2009 -2015 Co-Director, Section of Cardiovascular Cell and Tissue Engineering, Cardiovascular Research Center @
2005 -2009 Director, Human Embryonic Stem Cell Consortium @
2006 -2009 Associate Investigator, Institute of Pediatric Regenerative Medicine @
2005 -2009 Adjunct Associate Professor, Division of Cardiology, Department of Medicine @
2003 -2005 Assistant Professor, Cellular and Molecular Medicine @
2002 -2005 Assistant Professor of Medicine @
2001 -2001 Research Assistant Professor @
Ronald Li Education
The Johns Hopkins University School of Medicine 1998-2001
University of Toronto
Doctor of Philosophy (Physiology, Philosophy)
1995-1998
University of Waterloo
Bachelor of Science (Biotechnology, Biochemistry)
1990-1994
Diocesan Boys School, Hong Kong 1983-1989
Ronald Li Summary
Ronald Li, based in Boston, MA, US, is currently a Chief Executive Officer at Medera Biopharmaceutical. Ronald Li brings experience from previous roles at Sardocor Therapeutics, Karolinska Institutet, Novoheart and The University of Hong Kong. Ronald Li holds a 1998 - 2001 The Johns Hopkins University School of Medicine. Ronald Li has 1 emails on RocketReach.
Looking for a different Ronald Li?
Find contact details for 700 million professionals.